About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Chicago | 381 Studies

Clinical Trials Prostate CancerChicago

Prostate Cancer Clinical Trials in Chicago

Find 381 clinical trials for prostate cancer near Chicago, Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 381 trials

TerminatedSafety and Efficacy of Kanglaite Gelcaps in Prostate CancerThis research is being done to evaluate the safety and efficacy of the investigational Kanglaite gelcap (KLTc) on PSA in men with prostate cancer when given for twelve months.NCT01483586·Chicago, Illinois and 4 others CompletedSafety Study of MGA271 in Refractory CancerThe purpose of this study is to evaluate the safety of MGA271 when given by intravenous (IV) infusion to patients with refractory cancer.NCT01391143·Los Angeles, California and 11 others CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingAbiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsThis is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).NCT03012321·Los Angeles, California and 15 others

CompletedA Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100A study to assess the safety of continued administration of MDV3100 in subjects with Prostate Cancer who have already undergone treatment with MDV3100 and showed benefit.NCT01534052·Aurora, Colorado and 6 others

CompletedBicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerThe purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in…NCT00657904·Birmingham, Alabama and 84 others

Active not recruitingFeasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerThe purpose of this study is see if quality of life is improved in patients receiving oral hormone therapy compared to standard of care.NCT01342367·Chicago, Illinois

CompletedCYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate CancerThis randomized phase II trial studies how well glycosylated recombinant human interleukin-7 (CYT107) after vaccine therapy works in treating patients with castration-resistant…NCT01881867·La Jolla, California and 15 others

CompletedContinuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228The purpose of this study is to evaluate the safety and tolerability of extended treatment with FK228 in patients with metastatic renal cell carcinoma or hormone refractory…NCT00106301·Duarte, California and 4 others

CompletedToremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyAndrogen deprivation therapy (ADT) treatment for prostate cancer decreases the natural hormone called testosterone.NCT00129142·Homewood, Alabama and 154 others

CompletedAssessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenThe purpose of this study is to examine the effect of dutasteride on the inhibition of low-risk, localized prostate cancer progression in men who would otherwise receive no active…NCT00363311·Little Rock, Arkansas and 81 others

SuspendedA Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsThis is a first in human, single arm, open label, Phase 1a/1b study to determine the safety, feasibility, and efficacy of a single dose of NeoTCR-P1 T cells in participants with…NCT03970382·Duarte, California and 8 others

CompletedStudy of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men with metastatic…NCT03834493·Mobile, Alabama and 258 others

CompletedEffect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate CancerThe purpose of this study is to determine if the drug dutasteride increases expression of genes that slow the growth of prostate cancer during treatment with intermittent androgen…NCT00668642·Chicago, Illinois and 2 others

CompletedRandomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateThis was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate.NCT05605964·Mobile, Alabama and 107 others

CompletedThe Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate CancerThe proposed clinical trial will study the effects of 12 months of therapy with ARN-509 alone, or in combination with an LHRH agonist (LHRHa), each compared with LHRHa alone, in…NCT01790126·Scottsdale, Arizona and 4 others

CompletedDocetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyThis randomized phase III trial is studying docetaxel, prednisone, and bevacizumab to see how well they work compared to docetaxel and prednisone in treating patients with…NCT00110214·New Haven, Connecticut and 1 other

Active not recruitingPivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerA prospective, multi-center, single-arm study, planned in 150 patients.NCT02766543·Los Angeles, California and 13 others

RecruitingProstate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyThis study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive).NCT04472338·Duarte, California and 7 others

Completed3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical ProstatectomyIn April 2011, the United States Food and Drug Administration (FDA) approved the oral drug abiraterone acetate (Zytiga ®) in combination with prednisone (a steroid) to treat…NCT01751451·Chicago, Illinois and 15 others

PreviousPage 14 of 20Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma